Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 藥學專業學院
  4. 臨床藥學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/95153
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor黃彥銘zh_TW
dc.contributor.advisorYen-Ming Huangen
dc.contributor.author楊裕萌zh_TW
dc.contributor.authorYu-Meng Yangen
dc.date.accessioned2024-08-29T16:20:27Z-
dc.date.available2024-08-30-
dc.date.copyright2024-08-29-
dc.date.issued2024-
dc.date.submitted2024-07-26-
dc.identifier.citation1. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation. 2021;
2. Janssen LMM, Hiligsmann M, Elissen AMJ, et al. Burden of Disease of Type 2 Diabetes Mellitus: Cost of Illness and Quality of Life Estimated Using the Maastricht Study. Diabetic Medicine. 2020;37(10):1759-1765.
3. Pan Wen-Han. Nutrition and health survey in Taiwan (NAHSIT) report 2017-2020. 2022. Accessed Nov. 12, 2023.
4. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health. 2020;10(1):107-111.
5. Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2019: Results. 2020. Accessed Nov. 12, 2023. https://vizhub.healthdata.org/gbd-results/
6. Safiri S, Karamzad N, Kaufman JS, et al. Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019. Frontiers in Endocrinology. 2022;13:838027.
7. Ahmad FB, Cisewski JA, Xu J, Anderson RN. Provisional Mortality Data - United States, 2022. Morbidity and Mortality Weekly Report. 2023;72(18):488-492.
8. Ministry of Health and Welfare. 2022 Cause of Death Statistics in Taiwan. 2023. Accessed Nov. 12, 2023.
9. Bukhsh A, Goh BH, Zimbudzi E, et al. Type 2 Diabetes Patients’ Perspectives, Experiences, and Barriers Toward Diabetes-Related Self-Care: A Qualitative Study From Pakistan. Frontiers in Endocrinology. 2020;11:534873.
10. Egede LE, Gebregziabher M, Dismuke CE, et al. Medication Nonadherence in Diabetes: Longitudinal Effects on Costs and Potential Cost Savings from Improvement. Diabetes Care. 2012;35(12):2533-9.
11. Brown MT, Bussell JK. Medication Adherence: WHO Cares? Mayo Clinic Proceedings. 2011;86(4):304-314.
12. Zheng Y, Ley SH, Hu FB. Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. Nature Reviews Endocrinology. 2018;14(2):88-98.
13. Institute of Medicine Committee on Capitalizing on Social, Science Behavioral Research to Improve the Public’s Health. Promoting Health: Intervention Strategies from Social and Behavioral Research. In: Smedley BD, Syme SL, eds. Promoting Health: Intervention Strategies from Social and Behavioral Research. National Academies Press (US); 2000.
14. Kwasnicka D, Dombrowski SU, White M, Sniehotta F. Theoretical Explanations for Maintenance of Behaviour Change: A Systematic Review of Behaviour Theories. Health Psychology Review. 2016;10(3):277-296.
15. Glanz K, Bishop DB. The Role of Behavioral Science Theory in Development and Implementation of Public Health Interventions. Annual Review of Public Health. 2010;31:399-418.
16. Lin CY, Updegraff JA, Pakpour AH. The Relationship Between the Theory of Planned Behavior and Medication Adherence in Patients with Epilepsy. Epilepsy & Behavior. 2016;61:231-236.
17. Yue Z, Li C, Weilin Q, Bin W. Application of the Health Belief Model to Improve the Understanding of Antihypertensive Medication Adherence Among Chinese Patients. Patient Education and Counseling. 2015;98(5):669-673.
18. Burkhart PV, Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Journal of Nursing Scholarship. 2003;35(3):207.
19. Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN. Medication Adherence and Glycemic Control Among Newly Diagnosed Diabetes Patients. British Medical Journal Open Diabetes Research & Care. 2017;5(1):e000429.
20. Khayyat SM, Mohamed MMA, Khayyat SMS, et al. Association Between Medication Adherence and Quality of Life of Patients with Diabetes and Hypertension Attending Primary Care Clinics: A Cross-Sectional Survey. Quality of Life Research. 2019;28(4):1053-1061.
21. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care. 2005;43(6):521-530.
22. Raum E, Krämer HU, Rüter G, et al. Medication Non-Adherence and Poor Glycaemic Control in Patients with Type 2 Diabetes Mellitus. Diabetes Research and Clinical Practice. 2012;97(3):377-84.
23. Khunti K, Seidu S, Kunutsor S, Davies M. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017;40(11):1588-1596.
24. Jannoo Z, Wah YB, Lazim AM, Hassali MA. Examining Diabetes Distress, Medication Adherence, Dabetes Self-Care Activities, Diabetes-Specific Quality of Life and Health-Related Quality of Life Among Type 2 Diabetes Mellitus Patients. Journal of Clinical & Translational Endocrinology. 2017;9:48-54.
25. Lam WY, Fresco P. Medication Adherence Measures: An Overview. BioMed Research International. 2015;2015:217047.
26. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
27. Velligan DI, Wang M, Diamond P, et al. Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications. Psychiatric Services. 2007;58(9):1187-92.
28. Lee J, Tay TR, Radhakrishna N, et al. Nonadherence in the Era of Severe Asthma Biologics and Thermoplasty. European Respiratory Journal. 2018;51(4)
29. Weldring T, Smith SM. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Services Insights. 2013;6:61-8.
30. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The Routine Use of Patient Reported Outcome Measures in Healthcare Settings. British Medical Journal. 2010;340:c186.
31. Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-Report Measures of Medication Adherence Behavior: Recommendations on Optimal Use. Translational Behavioral Medicine. 2015;5(4):470-82.
32. Song Y, Han HR, Song HJ, Nam S, Nguyen T, Kim MT. Psychometric Evaluation of Hill-Bone Medication Adherence Subscale. Asian Nursing Research. 2011;5(3):183-8.
33. Horne R, Weinman J. Self-Regulation and Self-Management in Asthma: Exploring The Role of Illness Perceptions and Treatment Beliefs in Explaining Non- adherence to Preventer Medication. Psychology & Health. 2002;17(1):17-32.
34. Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) among Low-Literacy Patients with Chronic Disease. Value in Health. 2009;12(1):118-123.
35. Lee JK, Grace KA, Foster TG, et al. How Should We Measure Medication Adherence in Clinical Trials and Practice? Therapeutics and Clinical Risk Management. 2007;3(4):685-90.
36. El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A Scoping Review of Studies Comparing the Medication Event Monitoring System (MEMS) with Alternative Methods for Measuring Medication Adherence. British Journal of Clinical Pharmacology. 2016;82(1):268-79.
37. Hartman L, Lems WF, Boers M. Outcome Measures for Adherence Data from a Medication Event Monitoring System: A Literature Review. Journal of Clinical Pharmacy and Therapeutics. 2019;44(1):1-5.
38. Woltmann EM, Valenstein M, Welsh DE, et al. Using Pharmacy Data on Partial Adherence to Inform Clinical Care of Patients with Serious Mental Illness. Psychiatric Services. 2007;58(6):864-7.
39. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and Poor Adherence: Optimal Cut-Point for Adherence Measures Using Administrative Claims Data. Current Medical Research and Opinion. 2009;25(9):2303-2310.
40. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons. Med Care. 2006;44(5):471-7.
41. Steiner JF, Prochazka AV. The Assessment of Refill Compliance Using Pharmacy Records: Methods, Validity, and Applications. Journal of Clinical Epidemiology. 1997;50(1):105-16.
42. Gupta P, Patel P, Štrauch B, et al. Risk Factors for Nonadherence to Antihypertensive Treatment. Hypertension. 2017;69(6):1113-1120.
43. Farmer KC. Methods for Measuring and Monitoring Medication Regimen Adherence in Clinical Trials and Clinical Practice. Clinical Therapeutics. 1999;21(6):1074-90; discussion 1073.
44. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487-497.
45. Wang W, Lau Y, Loo A, Chow A, Thompson DR. Medication Adherence and Its Associated Factors Among Chinese Community-Dwelling Older Adults with Hypertension. Heart & Lung. 2014;43(4):278-83.
46. Wong M, Jiang J, Griffiths S. Factors Associated with Antihypertensive Drug Compliance in 83 884 Chinese Patients: A Cohort Study. Journal of Epidemiology & Community Health. 2010;64(10):895-901.
47. Degli Esposti E, Sturani A, Di Martino M, et al. Long-Term Persistence with Antihypertensive Drugs in New Patients. Journal of Human Hypertension. 2002;16(6):439-444.
48. Marcum ZA, Zheng Y, Perera S, et al. Prevalence and Correlates of Self-Reported Medication Non-Adherence Among Older Adults with Coronary Heart Disease, Diabetes Mellitus, and/or Hypertension. Research in Social and Administrative Pharmacy. 2013;9(6):817-27.
49. Alkatheri AM, Albekairy AM. Does the Patients' Educational Level and Previous Counseling Affect Their Medication Knowledge? Annals of Thoracic Medicine. 2013;8(2):105-8.
50. Ayodapo AO, Elegbede OT, Omosanya OE, Monsudi KF. Patient Education and Medication Adherence among Hypertensives in a Tertiary Hospital, South Western Nigeria. Ethiopian Journal of Health Sciences. 2020;30(2):243-250.
51. Iversen MD, Vora RR, Servi A, Solomon DH. Factors Affecting Adherence to Osteoporosis Medications: A Focus Group Approach Examining Viewpoints of Patients and Providers. Journal of Geriatric Physical Therapy. 2011;34(2):72-81.
52. Gutierrez MM, Sakulbumrungsil R. Factors Associated with Medication Adherence of Hypertensive Patients in the Philippines: A Systematic Review. Clinical hypertensions. 2021;27(1):19.
53. de Guzman AB, Guevara KIJ, Guiang FJB, et al. Developing a Model of Medication Adherence Among Filipino Elderly. Educational Gerontology. 2013;39(5):298-313.
54. Coyoca GS, Chan CC, Jamero HJ, Teves GF, Tabil VG. Barriers to therapeutic regimen adherence of type II diabetes mellitus patients in Iligan City, Philippines. 2013:
55. Kim C, Feldman HI, Joffe M, Tenhave T, Boston R, Apter AJ. Influences of Earlier Adherence and Symptoms on Current Symptoms: A Marginal Structural Models Analysis. Journal of Allergy and Clinical Immunology. 2005;115(4):810-4.
56. Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: Understanding Patients' Adherence to Inhaled Medications. International Journal of Chronic Obstructive Pulmonary Disease. 2018;13:2767-2773.
57. Marzolini C, Elzi L, Gibbons S, et al. Prevalence of Comedications and Effect of Potential Drug-Drug Interactions in the Swiss HIV Cohort Study. Antiviral Therapy. 2010;15(3):413-23.
58. Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient Characteristics Associated with Medication Adherence. Clinical Medicine & Research. 2013;11(2):54-65.
59. Gast A, Mathes T. Medication Adherence Influencing Factors—An (Updated) Overview of Systematic Reviews. Systematic Reviews. 2019;8(1):112.
60. Ågård A, Ranjbar V, Strang S. Diabetes in the Shadow of Daily Life: Factors that Make Diabetes a Marginal Problem. Practical diabetes. 2016;33(2):49-53.
61. Suen YN, Yeung ETW, Chan SKW, et al. Integration of Biological and Psychological Illness Attributional Belief in Association with Medication Adherence Behaviour: A Path Analysis. Early Intervention in Psychiatry. 2021;15(6):1686-1695.
62. Black S, Maitland C, Hilbers J, Orinuela K. Diabetes Literacy and Informal Social Support: A Qualitative Study of Patients at a Diabetes Centre. Journal of Clinical Nursing. 2017;26(1-2):248-257.
63. Ben-Natan M, Noselozich I. Factors Affecting Older Persons’ Adherence to Prescription Drugs in Israel. Nursing & Health Sciences. 2011;13(2):164-169.
64. Rajpura J, Nayak R. Medication Adherence in a Sample of Elderly Suffering from Hypertension: Evaluating the Influence of Illness Perceptions, Treatment Beliefs, and Illness Burden. Journal of Managed Care & Specialty Pharmacy. 2014;20(1):58-65.
65. Náfrádi L, Nakamoto K, Schulz PJ. Is Patient Empowerment the Key to Promote Adherence? A Systematic Review of the Relationship Between Self-Efficacy, Health Locus of Control and Medication Adherence. Public Library of Science One. 2017;12(10):e0186458.
66. Omran D, Guirguis LM, Simpson SH. Systematic Review of Pharmacist Interventions to Improve Adherence to Oral Antidiabetic Medications in People with Type 2 Diabetes. Canadian Journal of Diabetes. 2012;36(5):292-299.
67. Krass I, Taylor SJ, Smith C, Armour CL. Impact on Medication Use and Adherence of Australian Pharmacists’ Diabetes Care Services. Journal of the American Pharmacists Association. 2005;45(1):33-40.
68. Grant RW, Devita NG, Singer DE, Meigs JB. Improving Adherence and Reducing Medication Discrepancies in Patients with Diabetes. Annals of Pharmacotherapy. 2003;37(7-8):962-969.
69. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and Evaluating Complex Interventions: The New Medical Research Council guidance. British Medical Journal. 2008;337
70. Michie S, Atkins L, West R. The Behaviour Change Wheel. A guide to designing interventions 1st ed Great Britain: Silverback Publishing. 2014;1003:1010.
71. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient Adherence to Medical Treatment: A Review of Reviews. BioMed Central Health Services Research. 2007;7:55.
72. Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review. Drugs Aging. 2017;34(2):97-113.
73. Bandura A. Social Foundations of Thought and Action. Englewood Cliffs, NJ. 1986;1986(23-28)
74. Boukhechba M, Baee S, Nobles AL, Gong J, Wells K, Barnes LE. A Social Cognitive Theory-based Framework for Monitoring Medication Adherence Applied to Endocrine Therapy in Breast Cancer Survivors. IEEE-EMBS International Conference on Biomedical and Health Informatics. 2018;2018:275-278.
75. Ruppar TM. Randomized Pilot Study of a Behavioral Feedback Intervention to Improve Medication Adherence in Older Adults with Hypertension. Journal of Cardiovascular Nursing. 2010;25(6):470-479.
76. Kucukarslan SN. A Review of Published Studies of Patients' Illness Perceptions and Medication Adherence: Lessons Learned and Future Directions. Research in Social and Administrative Pharmacy. 2012;8(5):371-382.
77. Ashraf M, Virk RN. Determinants of medication adherence in patients with HIV: Application of the health belief model. J Pak Med Assoc. May 2021;71(5):1409-1412.
78. Rosenstock IM. The Health Belief Model and Preventive Health Behavior. Health Education Monographs. 1974;2(4):354-386.
79. Alatawi YM, Kavookjian J, Ekong G, Alrayees MM. The Association Between Health Beliefs and Medication Adherence Among Patients with Type 2 Diabetes. Research in Social and Administrative Pharmacy. 2016;12(6):914-925.
80. Fisher JD, Fisher WA, Amico KR, Harman JJ. An Information-Motivation-Behavioral Skills Model of Adherence to Antiretroviral Therapy. Health Psychology. 2006;25(4):462.
81. Nelson LA, Wallston KA, Kripalani S, LeStourgeon LM, Williamson SE, Mayberry LS. Assessing Barriers to Diabetes Medication Adherence Using the Information-Motivation-Behavioral Skills Model. Diabetes Research and Clinical Practice. 2018;142:374-384.
82. Dilekler İ, Doğulu C, Bozo Ö. A Test of Theory of Planned Behavior in Type II Diabetes Adherence: The Leading Role of Perceived Behavioral Control. Current Psychology. 2021;40(7):3546-3555.
83. Fisher JD, Amico KR, Fisher WA, Harman JJ. The Information-Motivation- Behavioral Skills Model of Antiretroviral Adherence and Its Applications. Current HIV/AIDS Reports. 2008;5(4):193-203.
84. Shattuck D, Kerner B, Gilles K, Hartmann M, Ng'ombe T, Guest G. Encouraging Contraceptive Uptake by Motivating Men to Communicate About Family Planning: the Malawi Male Motivator Project. American Journal of Public Health. 2011;101(6):1089-1095.
85. Osborn CY, Amico KR, Cruz N, et al. A Brief Culturally Tailored Intervention for Puerto Ricans With Type 2 Diabetes. Health Education & Behavior. 2010;37(6):849-862.
86. Mayberry LS, Osborn CY. Empirical Validation of the Information - Motivation - Behavioral Skills Model of Diabetes Medication Adherence: A Framework for Intervention. Diabetes Care. 2014;37(5):1246-1253.
87. Yang C, Lee DTF, Chair SY. Validation and Adaption of an Information- Motivation-Behavioral Skills Model of Medication Adherence in Older Patients with Multimorbidity. Patient Education and Counseling. 2023;113:107756.
88. Ranahan M, Von Visger J, Kayler LK. Describing Barriers and Facilitators for Medication Adherence and Self‐Management Among Kidney Transplant Recipients Using the Information‐Motivation‐Behavioral Skills Model. Clinical Transplantation. 2020;34(6):e13862.
89. Zarani F, Besharat MA, Sadeghian S, Sarami G. The Effectiveness of the Information-Motivation-Behavioral Skills Model in Promoting Adherence in CABG Patients. Journal of Health Psychology. 2010;15(6):828-837.
90. Chang SJ, Choi S, Kim S-A, Song M. Intervention Strategies Based on Information-Motivation-Behavioral Skills Model for Health Behavior Change: A Systematic Review. Asian Nursing Research. 2014;8(3):172-181.
91. Mayberry LS, Osborn CY. Empirical Validation of the Information–Motivation– Behavioral Skills Model of Diabetes Medication Adherence: A Framework for Intervention. Diabetes Care. 2014;37(5):1246-1253.
92. Wolf EJ, Harrington KM, Clark SL, Miller MW. Sample Size Requirements for Structural Equation Models: An Evaluation of Power, Bias, and Solution Propriety. Educational and Psychological Measurement. 2013;76(6):913-934.
93. Boomsma A. Systems Under Indirect Observation: Causality, Structure, Prediction. The Robustness of Lisrel Against Small Sample Sizes in Factor Analysis Models; North-Holland Amsterdam: Amsterdam, The Netherlands. 1982:149-173.
94. Bentler PM, Chou C-P. Practical Issues in Structural Modeling. Sociological Methods & Research. 1987;16(1):78-117.
95. Thorndike RM. Book Review : Psychometric Theory (3rd ed.) by Jum Nunnally and Ira Bernstein New York: McGraw-Hill, 1994, xxiv + 752 pp. Applied Psychological Measurement. 1995;19(3):303-305.
96. Chiang H-T, Chang C-T. Introduction to and Application Analysis of Taiwan’s NHI-MediCloud System. Journal of Service Science Research. 2019;11(1):93-115.
97. Directorate-General of Budget of Executive Yuan, Republic of China. Report on The Survey of Family Income and Expenditure, 2022. 2023.
98. George J, Phun Y-T, Bailey MJ, Kong DC, Stewart K. Development and Validation of the Medication Regimen Complexity Index. Annals of Pharmacotherapy. 2004;38(9):1369-1376.
99. Norman CD, Skinner HA. eHEALS: The eHealth Literacy Scale. Journal of Medical Internet Research. 2006;8(4):e27.
100. Kim K, Shin S, Kim S, Lee E. The Relation Between eHealth Literacy and Health-Related Behaviors: Systematic Review and Meta-analysis. Journal of Medical Internet Research. 2023;25:e40778.
101. Mitsutake S, Shibata A, Ishii K, Okazaki K, Oka K. [Developing Japanese Version of the eHealth Literacy Scale (eHEALS)]. Nihon Koshu Eisei Zasshi. 2011;58(5):361-71.
102. Richtering SS, Hyun K, Neubeck L, et al. eHealth Literacy: Predictors in a Population With Moderate-to-High Cardiovascular Risk. Journal of Medical Internet Research Human Factors. 2017;4(1):e4.
103. van der Vaart R, van Deursen AJAM, Drossaert CHC, Taal E, van Dijk JAMG, van de Laar MAFJ. Does the eHealth Literacy Scale (eHEALS) Measure What it Intends to Measure? Validation of a Dutch Version of the eHEALS in Two Adult Populations. Journal of Medical Internet Research. 2011;13(4):e86.
104. Bandura A. Self-efficacy: Toward a Unifying Theory of Behavioral Change. Psychological Review. 1977;84(2):191.
105. Rosli NA, Mazapuspavina MY, Ismail Z, Elkudssiah Ismail N. Relationship of Self Efficacy in Medication Understanding with Quality of Life among Elderly with Type 2 Diabetes Mellitus on Polypharmacy in Malaysia. International Journal of Environmental Research and Public Health. 2022;19(5)
106. Cameron KA, Ross EL, Clayman ML, et al. Measuring Patients’ Self-Efficacy in Understanding and Using Prescription Medication. Patient Education and Counseling. 2010;80(3):372-6.
107. Cai Q, Ye L, Horne R, et al. Patients’ Adherence-Related Beliefs About Inhaled Steroids: Application of the Chinese Version of the Beliefs About Medicines Questionnaire-Specific in Patients with Asthma. Journal of Asthma. 2020;57(3):319-326.
108. Otero ME, van den Reek J, van de Kerkhof PCM, et al. Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study. Acta Dermato-Venereologica. 2019;99(4):386-392.
109. Foley L, Doherty AS, Wallace E, et al. Exploring the Multidimensional Relationship Between Medication Beliefs and Adherence to Medications Among Older Adults Living With Multimorbidity Using Polynomial Regression: An Observational Cohort Study. Annals of Behavioral Medicine. 2023;57(7):561-570.
110. Horne R, Weinman J, Hankins M. The Beliefs About Medicines Questionnaire: The Development and Evaluation of a New Method for Assessing the Cognitive Representation of Medication. Psychology & Health. 1999;14(1):1-24.
111. Jankowska-Polańska B, Świątoniowska-Lonc N, Karniej P, Polański J, Tański W, 
Grochans E. Influential Factors in Adherence to the Therapeutic Regime in Patients with Type 2 Diabetes and Hypertension. Diabetes Research and Clinical Practice. 2021;173:108693.
112. Vlacho B, Simarro FL, Mata-Cases M, et al. Adherence to Antidiabetic Treatment Among Patients Managed in Primary Care Centres in Spain: the INTENSE Study. Primary Care Diabetes. 2022;16(6):760-767.
113. Zairina E, Nugraheni G, Achmad GNV, et al. The Correlation Between Self- Related Adherence, Asthma-Related Quality of Life and Control of Asthma in Adult Patients. Journal of Basic and Clinical Physiology. 2021;32(4):453-458.
114. Chen Y-J, Chang J, Yang S-Y. Psychometric Evaluation of Chinese Version of Adherence to Refills and Medications Scale (ARMS) and Blood-Pressure Control Among Elderly with Hypertension. Patient Preference and Adherence. 2020:213- 220.
115. Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal Effects of Medication Nonadherence on Glycemic Control. Annals of Pharmacotherapy. 2014;48(5):562-70.
116. Kardas P, Lewek P, Matyjaszczyk M. Determinants of Patient Adherence: A Review of Systematic Reviews. Original Research. Frontiers in Pharmacology. 2013;4
117. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research. Public Library of Science Med. 2007;4(7):e238.
118. Ingersoll KS, Cohen J. The Impact of Medication Regimen Factors on Adherence to Chronic Treatment: A Review of Literature. Journal of Behavioral Medicine. 2008;31:213-224.
119. de Vries ST, Keers JC, Visser R, et al. Medication Beliefs, Treatment Complexity, 
and Non-Adherence to Different Drug Classes in Patients with Type 2 Diabetes. 
Journal of Psychosomatic Research. 2014;76(2):134-138.
120. Jaam M, Ibrahim MIM, Kheir N, Awaisu A. Factors Associated with Medication 
Adherence Among Patients with Diabetes in the Middle East and North Africa Region: A Systematic Mixed Studies Review. Diabetes Research and Clinical Practice. 2017;129:1-15.
121. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological Insulin Resistance in Patients with Type 2 Diabetes: The Scope of the Problem. Diabetes Care. 2005;28(10):2543-5.
122. Polonsky WH, Henry RR. Poor Medication Adherence in Type 2 Diabetes: Recognizing the Scope of the Problem and Its Key Contributors. Patient Preference and Adherence. 2016:1299-1307.
123. Karter AJ, Subramanian U, Saha C, et al. Barriers to Insulin Initiation: The Translating Research Into Action for Diabetes Insulin Starts Project. Diabetes Care. 2010;33(4):733-735.
124. Byrne J, Willis A, Dunkley A, et al. Individual, Healthcare Professional, and System-Level Barriers and Facilitators to Initiation and Adherence to Injectable Therapies for Type 2 Diabetes: A Systematic Review and Meta-Ethnography. Diabetic Medicine. 2022;39(1):e14678.
125. Oosterom-Calo R, van Ballegooijen AJ, Terwee CB, et al. Determinants of Adherence to Heart Failure Medication: A Systematic Literature Review. Heart Failure Reviews. 2013;18(4):409-427.
126. Krueger K, Botermann L, Schorr SG, Griese-Mammen N, Laufs U, Schulz M. Age-Related Medication Adherence in Patients with Chronic Heart Failure: A Systematic Literature Review. International Journal of Cardiology. 2015;184:728- 735.
127. Alexander DS, Hogan SL, Jordan JM, DeVellis RF, Carpenter DM. Examining Whether the Information-Motivation-Behavioral Skills Model Predicts Medication Adherence for Patients with a Rare Disease. Patient Preference and Adherence. 2017;11:75-83.
128. Acheson EE. Voclosporin: Drug information Accessed Dec 02, 2022.
129. Cosio D, Heckman TG, Anderson T, Heckman BD, Garske J, McCarthy J. 
Telephone-administered motivational interviewing to reduce risky sexual behavior in HIV-infected rural persons: a pilot randomized clinical trial. Sexually transmitted diseases. 2010;37(3):140-146.
130. Camargo-Plazas P, Robertson M, Alvarado B, Paré GC, Costa IG, Duhn L. Diabetes Self-Management Education (DSME) for Older Persons in Western Countries: A Scoping Review. Public Library of Science One. 2023;18(8):e0288797.
131. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-Management Education for Adults with Type 2 Diabetes: A Meta-Analysis of the Effect on Glycemic Control. Diabetes Care. 2002;25(7):1159-1171.
132. Norris SL, Engelgau MM, Narayan KM. Effectiveness of Self-Management Training in Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Diabetes Care. 2001;24(3):561-587.
133. Nature’s 10. Nature. 2016/12/01 2016;540(7634):507-515.
134. Amico KR, Barta W, Konkle-Parker DJ, et al. The Information–Motivation–Behavioral Skills Model of ART Adherence in a Deep South HIV+ Clinic Sample. AIDS and Behavior. 2009;13(1):66-75.
135. Smith B, Magnani JW. New Technologies, New Disparities: The Intersection of Electronic Health and Digital Health Literacy. International Journal of Cardiology. 2019;292:280-282.
136. Verweel L, Newman A, Michaelchuk W, Packham T, Goldstein R, Brooks D. The Effect of Digital Interventions on Related Health Literacy and Skills for Individuals Living with Chronic Diseases: A Systematic Review and Meta- Analysis. International Journal of Medical Informatics. 2023;177:105114.
137. Hickman RL, Clochesy JM, Alaamri M. Effects of an eHealth Intervention on Patient-Provider Interaction and Functional Health Literacy in Adults with Hypertension. SAGE Open Nursing. 2021;7:23779608211005863.
138. Grossman LV, Masterson Creber RM, Benda NC, Wright D, Vawdrey DK, Ancker JS. Interventions to Increase Patient Portal Use in Vulnerable Populations: A Systematic Review. Journal of the American Medical Informatics Association. 2019;26(8-9):855-870.
139. Redfern J, Coorey G, Mulley J, et al. A Digital Health Intervention for Cardiovascular Disease Management in Primary Care (CONNECT) Randomized Controlled Trial. NPJ Digital Medicine. 2020;3(1):117.
140. Farmer A, Kinmonth A-L, Sutton S. Measuring Beliefs About Taking Hypoglycaemic Medication Among People with Type 2 Diabetes. Diabetic Medicine. 2006;23(3):265-270.
141. Horne R, Weinman J. Patients' Beliefs About Prescribed Medicines and Their Role in Adherence to Treatment in Chronic Physical Illness. Journal of Psychosomatic Research. 1999;47(6):555-567.
142. Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding Patients’ Adherence-Related Beliefs About Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework. Public Library of Science ONE. 2013;8(12):e80633.
143. Shiyanbola OO, Farris KB, Chrischilles E. Concern Beliefs in Medications: Changes Over Time and Medication Use Factors Related to a Change in Beliefs. Research in Social and Administrative Pharmacy. 2013;9(4):446-457.
144. Stevenson FA, Cox K, Britten N, Dundar Y. A Systematic Review of the Research on Communication Between Patients and Health Care Professionals About Medicines: the Consequences for Concordance. Health expectations. 2004;7(3):235-245.
145. Granger BB, Ekman I, Hernandez AF, et al. Results of the Chronic Heart Failure Intervention to Improve Medication Adherence Study: A Randomized Intervention in High-Risk Patients. American Heart Journal. 2015;169(4):539-548.
146. Rollnick S, Miller WR. What Is Motivational Interviewing? Behavioural and Cognitive Psychotherapy. 1995;23(4):325-334.
147. Papus M, Dima AL, Viprey M, Schott A-M, Schneider MP, Novais T. Motivational Interviewing to Support Medication Adherence in Adults with Chronic Conditions: Systematic Review of Randomized Controlled Trials. Patient Education and Counseling. 2022;105(11):3186-3203.
148. DiMatteo MR, Haskard KB, Williams SL. Health Beliefs, Disease Severity, and Patient Adherence: A Meta-Analysis. Medical Care. 2007;45(6)
149. Jones CJ, Smith H, Llewellyn C. Evaluating the Effectiveness of Health Belief Model Interventions in Improving Adherence: A Systematic Review. Health Psychology Review. 2014;8(3):253-269.
150. Carpenter CJ. A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Commun. Dec 2010;25(8):661-9.
151. Gellad WF, Grenard JL, Marcum ZA. A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity. The American Journal of Geriatric Pharmacotherapy. 2011;9(1):11- 23.
152. Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors Associated with Medication Refill Adherence in Cardiovascular-Related Diseases: A Focus on Health Literacy. Journal of General Internal Medicine. 2006;21(12):1215-1221.
153. Hsu C, Lemon JM, Wong ES, et al. Factors Affecting Medication Adherence: Patient Perspectives from Five Veterans Affairs Facilities. BioMed Central Health Services Research. 2014;14:533. 

-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/95153-
dc.description.abstract研究背景與重要性:第二型糖尿病的高盛行率及其衍生的潛在併發症,使得其控制變得至關重要。雖然藥物在第二型糖尿病的治療過程中扮演關鍵的角色,仍有許多人難以依照醫師處方服用藥物。現有研究指出諸多因素皆可能影響病人的服藥行為,卻沒有公認一致的準則讓醫療專業人員識別服藥順從性不佳的病人,而提供相對應的服務以增進病人的服藥行為。應用行為理論以了解病人服藥行為,可以系統性地去探索影響病人服藥順從性不佳的原因,進而提供臨床健康照護介入措施之基礎,以提升病人服藥順從性。
研究目的:本研究使用資訊-動機-行為技能模型,(1) 檢驗影響第二型糖尿病病人 服藥順從性的因素;(2) 加入糖化血色素作為臨床療效指標來延伸研究模型,探 索影響服藥順從性與糖化血色素的可能因素。
研究方法:本橫斷性研究以資訊-動機-行為技能模型作為理論基礎,檢驗影響服藥順從性的因素。於 2023 年 9 月至 2024 年 5 月期間在五間社區藥局以自填式問卷進行資料收集。符合條件的受試者為能理解繁體中文並被診斷為第二型糖尿病 的 18 歲以上成年人,且至少服用一種口服糖尿病藥品。研究問卷內容共 46 題,除人口統計學與臨床資訊(8 題)外,還評估受試者的電子健康素養(8 題)、藥品信念(10 題)、自我效能(8 題)和服藥順從性(12 題)。本研究問卷約需 10-15 分鐘內即可完成,糖化血色素和用藥複雜度將透過全民健康保險雲端藥歷系統記錄獲得,本研究中服藥順從性行為可分為服藥和領藥兩部分。以路徑分析探索影響服藥和領藥行為的人口統計學和心理社會因素之潛在路徑,並透過模型修正指數進行較佳模型適配性評估和調整。
研究結果:本研究共招募 273 名受試者,平均年齡為 67.72 歲,其中 52.01%為女性。糖化血色素與病人自述的用藥行為呈負相關(β = -0.198, p < 0.001)。此外,年齡較大(β = 0.138, p = 0.025)、教育程度較低(β = 0.139, p = 0.020)、注射藥品較少(β = 0.136, p = 0.038)、對藥品的擔憂較低(β = 0.165, p = 0.003)、自我效能較好(β = 0.257, p < 0.001)的病人較可能按時服用糖尿病藥品。結果也顯示透過自我效能的中介效果,較高電子健康素養(間接效應,β = 0.045, p = 0.010)、對藥品的擔憂較低(間接效應,β = 0.079, p = 0.001)以及對藥品必要性的信念較高(間接效應,β = 0.032, p = 0.047)與較佳的病人的服藥行為相關。在領藥行為的結果方面,按時領藥的受試者(β = 0.120, p = 0.028)和第二型糖尿病用藥服雜度較低的受試者(β = 0.395, p < 0.001)更有可能擁有較低的糖化血色素。此外,年齡較大的成年人(β = 0.180, p = 0.008)傾向於按照處方建議領取他們的糖尿病藥品。
結論:未來的糖尿病介入措施應聚焦病人自我效能的增強,根據不同電子健康素養的族群設計適合的資訊,減少他們對藥品的擔憂,並同時強調持續用藥的重要性。此外,在設計健康照護介入措施時,還須考慮目標族群文化差異與病人基本特質。
zh_TW
dc.description.abstractBackground
Managing type 2 diabetes mellitus (T2DM) is crucial, which can lead to serious complications if not handled properly, yet many individuals struggle with adhering to their prescribed treatments. Incorporating the behavioral theory models into studies offers researchers a structured framework for assessing health behaviors, provides insights into behaviors, and facilitates the development of tailored interventions to improve medication adherence. Despite extensive studies globally, no universal standard for enhancing medication adherence among patients with T2DM has been proposed, underlying a significant gap in diabetes management.
Objectives
This study aimed to address two objectives: (1) to examine the factors influencing medication adherence among patients with T2DM using the Information-Motivation- Behavioral skills (IMB) model, and (2) to identify key factors of medication adherence and link the model to A1C levels.
Methods
This cross-sectional study adopted the IMB model to examine factors influencing medication adherence. A 46-item questionnaire was administered face-to-face at five community pharmacies from September 2023 to May 2024. Eligible participants were adults who understood Traditional Chinese, were diagnosed with T2DM, and were taking at least one oral diabetes medication. In addition to collecting demographic and clinical information (8 items), we measured participants’ eHealth literacy (8 items), belief in medicines (10 items), self-efficacy (8 items), and medication adherence (12 items). Completing the questionnaire took approximately 10-15 minutes. The A1C level and medication regimen complexity index (MRCI) were obtained from the National Health Insurance PharmaCloud System. Medication adherence was divided into medication-taking and medication-refill. Path analysis was conducted to explore potential pathways linking demographics and psychosocial factors relevant to medication-taking and refill. Model fit indices were evaluated, and modification indices were applied to adjust the preferred models.
Results
Two hundred and seventy-three participants were recruited for the study, with an average age of 67.72 years and 52.01% being females. The A1C level was negatively associated with self-reported adherence to medication-taking behavior (β = -0.198, p < 0.001). Besides, individuals with older age (β = 0.138, p = 0.025), lower educational levels (β = 0.139, p = 0.020), fewer injectable medications (β = 0.136, p = 0.038), fewer concerns about medications (β = 0.165, p = 0.003), and better self-efficacy (β = 0.257, p < 0.001) were more likely to adhere to their diabetes medications. Medication-taking behavior was also improved in individuals with higher eHealth literacy (indirect effects, β = 0.045, p = 0.010), fewer concerns about medications (indirect effects, β = 0.079, p = 0.001), and stronger beliefs in medication necessity (indirect effects, β = 0.032, p = 0.047) through enhanced self-efficacy. Regarding medication-refill behaviors, participants who refilled their prescription less on schedule (β = 0.120, p = 0.028) and had a higher T2DM MRCI (β = 0.395, p < 0.001) tended to have higher A1C levels. Moreover, older adults (β = 0.180, p = 0.008) were apt to refill their diabetes medications as recommended.
Conclusion
The study identified the potential factors, based on the IMB model, influencing medication-taking and refill behaviors, highlighting the importance of medication-taking in managing T2DM. As a result, future diabetes interventions should prioritize enhancing patients’ self-efficacy, addressing eHealth literacy, alleviating concerns about medications while underlining the importance of adhering to medications. Additionally, it is also crucial to consider cultural adaptations and differences in patients’ baseline characteristics when developing tailored interventions.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-29T16:20:27Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2024-08-29T16:20:27Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents口試委員會審定書 i
誌謝 ii
摘要 iii
Abstract v
圖次 xi
表次 xii
Chapter 1. Introduction 1
1.1 Background and significance 1
1.2 Medication adherence to type 2 diabetes mellitus 2
1.3 Purpose of the study 3
1.4 Study objectives 3
Chapter 2. Literature Review 4
2.1 The relationship of medication adherence and diabetes control 4
2.2 Medication adherence measurement 5
2.3 Contributing factors of medication adherence 8
2.4 Behavioral theory application in medication adherence 11
2.5 Summary 13
Chapter 3. Methods 14
3.1 Conceptual framework 14
3.2 Study design and setting 15
3.2.1 Sample size 16
3.2.2 Selection criteria 16
3.2.3 Data collection 16
3.3 Measurements of the constructs 17
3.3.1 Demographic backgrounds and clinical characteristics 17
3.3.2 The eHealth Literacy Scale (eHEALS) 18
3.3.3 The Medication Understanding and Use Self-Efficacy (MUSE) 18
3.3.4 The Beliefs about Medicines Questionnaire-Specific (BMQ-Specific) 19
3.3.5 The Adherence to Refills and Medications Scale (ARMS) 20
3.4 Data analysis 20
Chapter 4. Results 22
4.1 Baseline characteristics 22
4.2 Questionnaires results 26
4.3 Bivariate correlation matrix 27
4.4 Path analysis 29
4.4.1 The path models of medication-taking behavior without A1C levels 29
4.4.2 The path models of medication-taking behavior with A1C levels 36
4.4.3 The path models of medication-refill behavior without A1C levels 43
4.4.4 The path models of medication-refill behavior with A1C levels 49
Chapter 5. Discussion 55
5.1 Relationships associated with A1C levels 55
5.2 Relationships between medication-taking behavior, sociodemographic information, and clinical characteristics 55
5.3 Relationships between medication-taking behavior and self-efficacy 57
5.4 Relationships between medication-taking behavior and the eHealth literacy 58
5.5 Relationships between medication-taking behavior and the motivation 60
5.6 Relationships between A1C levels, medication-refill behavior, and factors from the IMB models 63
5.7 Study strengths 64
5.8 Study limitations 65
Chapter 6. Conclusion 67
References 68
Appendices 87
Appendix A: Participants informed consent form 87
Appendix B: Study questionnaires 91
-
dc.language.isoen-
dc.subject電子健康素養zh_TW
dc.subject路徑分析zh_TW
dc.subject第二型糖尿病zh_TW
dc.subject健康行為zh_TW
dc.subject資訊-動機-行為技能模型zh_TW
dc.subject服藥順從性zh_TW
dc.subject自我效能zh_TW
dc.subjectpath analysisen
dc.subjectself-efficacyen
dc.subjecteHealth literacyen
dc.subjectInformation-Motivation-Behavioral skills modelen
dc.subjecthealth-related behavioren
dc.subjecttype 2 diabetes mellitusen
dc.subjectmedication adherenceen
dc.title以資訊-動機-行為技能模型探討第二型糖尿病人服藥順從性之影響因素zh_TW
dc.titleUsing the Information-Motivation-Behavioral Skills Model to Explore Factors of Medication Adherence in Patients with Type 2 Diabetes Mellitusen
dc.typeThesis-
dc.date.schoolyear112-2-
dc.description.degree碩士-
dc.contributor.oralexamcommittee王繼娟;林香汶;何藴芳;詹勲育zh_TW
dc.contributor.oralexamcommitteeChi-Chuan Wang;Hsiang-Wen Lin;Yunn-Fang Ho;Hsun-Yu Chanen
dc.subject.keyword第二型糖尿病,服藥順從性,健康行為,資訊-動機-行為技能模型,電子健康素養,自我效能,路徑分析,zh_TW
dc.subject.keywordmedication adherence,type 2 diabetes mellitus,health-related behavior,Information-Motivation-Behavioral skills model,eHealth literacy,self-efficacy,path analysis,en
dc.relation.page98-
dc.identifier.doi10.6342/NTU202402230-
dc.rights.note同意授權(全球公開)-
dc.date.accepted2024-07-29-
dc.contributor.author-college醫學院-
dc.contributor.author-dept臨床藥學研究所-
dc.date.embargo-lift2029-07-24-
顯示於系所單位:臨床藥學研究所

文件中的檔案:
檔案 大小格式 
ntu-112-2.pdf
  此日期後於網路公開 2029-07-24
3.51 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved